Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Palbociclib Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021 3 0
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 9 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Temsirolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Everolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0